ACSD Granted Significant Telemedicine Patent
We’re proud to announce that ACSD has been granted another U.S. patent for our innovative Cardiac Monitoring CORE technology, specifically advancing the capabilities of ambulatory ECG.
This latest patent reinforces our commitment to delivering versatile and efficient cardiac monitoring solutions. Our patented CORE devices support multiple test modalities—including Holter, Event, Mobile Cardiac Telemetry (MCT), and EKG—all within a single device. Clinicians can select the appropriate test based on patient needs, without requiring multiple pieces of equipment.
What sets this patent apart is its focus on individual ambulatory cardiac devices that integrate more than one testing modality, streamlining the diagnostic process and enhancing patient care in both clinical and remote settings.
This milestone marks our fifth patent for the CORE platform and is a testament to the dedication and innovation of the ACSD team. Our growing portfolio of patents is helping to shape the future of cardiac monitoring technology.
To learn more about our intellectual property and the technologies behind it, visit: acsd4u.com/patents